Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

BACKGROUND: Global assessment allows patients to assess improvement in multiple irritable bowel syndrome (IBS) symptoms. However, it was deemed important to assess “clinically meaningful improvements, focusing on the patient’s chief complaint and the severity of major IBS symptoms” in addition to gl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biopsychosoc Med
Main Authors: Ida, Motoko, Nishida, Akito, Akiho, Hiraku, Nakashima, Yoshihiro, Matsueda, Kei, Fukudo, Shin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356323/
https://ncbi.nlm.nih.gov/pubmed/28331539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13030-017-0093-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados